TessMed

TessMed was a medical device company focused on developing innovative solutions for women's pelvic health, specifically targeting pelvic organ prolapse (POP). The company's flagship product, the Tessera system, provided a mesh-less surgical alternative for pelvic floor reconstruction, aiming to reduce the complications associated with traditional synthetic mesh implants. By utilizing a proprietary anchoring system and the patient's own tissue, TessMed sought to improve surgical outcomes and patient safety in urogynecology. The company was founded by leading experts in pelvic medicine to address the significant unmet needs in the treatment of pelvic floor disorders. Although the company is no longer active, its technology represented a significant attempt to innovate within the constraints of the FDA's mesh safety communications.